Back to search

Article

Targeting CXCR1 and CXCR2 to overcome radiotherapy resistance in PTEN-deficient prostate carcinoma

2020-03-16

Abstract excerpt

<h4> ABSTRACT </h4> Functional impairment of the tumour-suppressor PTEN is common in primary-prostate cancer and has been linked to relapse post-radiotherapy (RT). Pre-clinical modelling supports elevated CXC-chemokine signaling as a critical mediator of PTEN -depleted disease progression and therapeutic resistance. We assessed the correlation of PTEN -deficiency with CXC-chemokine signaling and its associati...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5eff399d-1fd1-5001-ac0b-7d2d7df9c562
DOI
10.1101/2020.03.16.993394
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeting CXCR1 and CXCR2 to overcome radiotherapy resistance in PTEN-deficient prostate carcinomaDOI 10.1101/2020.03.16.993394
Select a neighboring publication to make it the new centre.